Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Medtronic
US Army
Queensland Health
Merck
Federal Trade Commission
Cerilliant
Healthtrust
Farmers Insurance

Generated: April 22, 2018

DrugPatentWatch Database Preview

LORABID Drug Profile

« Back to Dashboard

When do Lorabid patents expire, and what generic alternatives are available?

Lorabid is a drug marketed by King Pharms and is included in two NDAs.

The generic ingredient in LORABID is loracarbef. Additional details are available on the loracarbef profile page.
Drug patent expirations by year for LORABID
Synonyms for LORABID
(6R,7S)-7-[(2R)-2-amino-2-phenylacetamido]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7S)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-7-{[(2R)-2-ammonio-2-phenylacetyl]amino}-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-Azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2R)-aminophenylacetyl)amino)-3-chloro-8-oxo-, (6R,7S)-
1-Azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6R-(6alpha,7beta(R*)))-
1-Azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, 7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-, (6R,7S)-
76470-66-1
7beta-[(2R)-2-amino-2-phenylacetyl]nitrilo-3-chloro-3,4-didehydrocepham-4-carboxylate
7beta-[(2R)-2-amino-2-phenylacetyl]nitrilo-3-chloro-3,4-didehydrocepham-4-carboxylic acid
7beta-[(2R)-2-ammonio-2-phenylacetyl]nitrilo-3-chloro-3,4-didehydrocepham-4-carboxylate
AC1NR4Q4
AKOS015895936
Anhydrous loracarbef
API0004680
BIDD:GT0753
BRD-K28935038-001-01-4
CCG-220611
CHEBI:47544
CHEMBL1013
CTK2H7568
D08143
D0E9WL
DB00447
DTXSID7023223
I06-1267
JAPHQRWPEGVNBT-UTUOFQBUSA-N
KT 3777
KT-3777
Lorabid (TN)
loracarbef
Loracarbef (INN)
Loracarbef [USAN:INN:BAN]
Loracarbef hydrate
Loracarbef monohydrate
LORACARBEF, ANHYDROUS
Loracarbefum
Loracarbefum [INN-Latin]
Lorafem
Lorbef (TN)
Loribid
LY 163892
LY-163892
LY163892
SCHEMBL34153
UNII-W72I5ZT78Z
W72I5ZT78Z
ZINC1530993

US Patents and Regulatory Information for LORABID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms LORABID loracarbef CAPSULE;ORAL 050668-001 Dec 31, 1991 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
King Pharms LORABID loracarbef FOR SUSPENSION;ORAL 050667-002 Dec 31, 1991 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
King Pharms LORABID loracarbef CAPSULE;ORAL 050668-002 Apr 5, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
King Pharms LORABID loracarbef FOR SUSPENSION;ORAL 050667-001 Dec 31, 1991 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Harvard Business School
Chinese Patent Office
Cantor Fitzgerald
UBS
Fuji
McKesson
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.